Type 2 diabetes is increasing in epidemic proportions across the globe. Obesity is generally considered to be the major contributor to the epidemic of diabetes mellitus. In NHANES 1999–2002 study from USA around 55% of diabetics were obese (Eberhardt & Ogden, 2004) The focus in the Western world remains on the more prevalent overweight or obese patient, but a significant proportion of diabetes ...

estrogen might play an important role in the pathogenesis of diabetes mellitus type 2. estrogens inhibit diabetes via distinct mechanisms particularly by reducing both hyperglycemia and plasma insulin levels. estrogen exerts its physiological effects mainly through estrogen receptors including α and β types. estrogen receptors are found in many tissues that participate in the pathogenesis of ty...

Pancreatic cancer (PC) is the fourth leading cause of death among all types cancer. PC very aggressive with a low 5-year overall survival rate. The highest prevalence diabetes mellitus (DM), significantly exceeding average population, registered patients prostate Recommendations for systemic screening detection are not standardized. purpose this review to present an analysis current literature ...

background: nephrotic syndrome and type 1 diabetes mellitus are two common chronic conditions in children. co-existence of these conditions is an extremely rare finding. case presentation: this report presents a 6-year-old boy who was diagnosed with nephrotic syndrome five years ago and type 1 diabetes mellitus in infancy. renal biopsy showed membranous glomerulonephritis, which is a rare histo...

Context Multiple consensus statements decree that women with diabetes mellitus should have comparable birth outcomes to women without diabetes mellitus; however, there is a scarcity of contemporary population-based studies on this issue. Objective To examine temporal trends in obstetric interventions and perinatal outcomes in a population-based cohort of women with type 1, type 2, or gestatio...

conclusions in critically ill patients, the symptoms of hypophosphatemia may not be apparent, but clinicians should be vigilant about this complication during therapy. in cases of severe symptoms (e.g., cardiopulmonary distress, anemia and thrombocytopenia, or rhabdomyolysis), phosphate therapy under close surveillance is warranted. introduction although asymptomatic hypophosphatemia is a commo...